Mucinous Breast Cancer Stage II Completed Phase 2 / 3 Trials for Paclitaxel (DB01229)

Also known as: Mucinous breast carcinoma / Mucinous carcinoma of breast

IndicationStatusPhase
DBCOND0053761 (Mucinous Breast Cancer Stage II)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01426880Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast CancerTreatment